Lumera Corporation Announces DARPA SBIR Contract

Lumera Corporation (NASDAQ:LMRA), a leader in the field of photonic communications, announced today that it has been awarded a Defense Advanced Research Projects Agency (DARPA) phase I Small Business Innovation Research contract in the amount of $98,933 to design and fabricate polymer devices. Upon successful completion of certain milestones, Lumera could receive a subsequent contract in the range of $750,000. "It is gratifying to see, by this contract award, DARPA’s confidence in our capabilities to develop superior electro-optic polymer materials,” said Dr. Raluca Dinu, Vice President, Electro-Optic Business Unit. "The final goal and end product of the contract will be to economically produce high bandwidth, small chip, stable, low voltage, low loss, ultra linear high EO coefficient polymer directional coupler modulators. We are up to the task and look forward to reaching that objective.” About Lumera Lumera is a leader in photonic communications. The company designs electro-optic components based on proprietary polymer compounds for the telecommunications and computing industries. Through its wholly owned subsidiary, Plexera Bioscience LLC, the company is also in the bioscience industry. Plexera is focused on providing the life sciences market with tools, content, and methods to simplify and accelerate proteomic discovery for therapeutic antibodies as well as predictive biomarkers. For more information, please visit www.lumera.com. Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.